Was the 2026 IPO Wave Actually Historic?

On paper, 2026 was a blockbuster year for IPOs: roughly $111 billion raised across 76 deals, up about 625% from 2025 and the biggest haul since the 2021 peak. But there's a catch that reshapes the entire story — SpaceX's record-shattering $75B debut accounts for roughly 67% of all 2026 IPO proceeds on its own.

Strip out that single deal and the other 75 IPOs raised about $36B combined — actually below 2025's full-year pace. This dashboard tracks every notable 2026 IPO with its raise, debut valuation, first-day pop, and sector, so you can see the real shape of the market underneath the headline number.

Key Findings

• One name carries the year: SpaceX ($75B) is 67% of all 2026 proceeds — 2026 is concentration, not breadth
• Not 2021 redux: 2021 had ~1,000 IPOs and ~$300B on SPAC mania; 2026 has record dollars but deal count down 18%
• Biotech's quiet boom: its best IPO quarter since 2021 — and both the year's best debut (Veradermics +122%) and worst
• The AI giants haven't priced: Anthropic and OpenAI have filed but remain private marks, not IPO valuations

What the Dashboard Covers

Every notable IPO that priced in 2026 — from SpaceX and Cerebras to the biotech wave (Veradermics, Kailera, Hemab), crypto (BitGo), quantum (Quantinuum) and the flops (Presto-style SPAC busts). Plus the pipeline of trillion-dollar names still on the runway, and the 2025 class for context. Sortable by raise or first-day pop, filterable by sector.